Terkko Navigator / Respiratory Medicine/ Feeds

Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non–Small Cell Lung Cancer After Platinum Chemotherapy

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma

The Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity-Score Matched Analysis

Chemotherapy and Radiation versus Chemotherapy Alone for Elderly Patients with N3 Stage IIIB NSCLC

Outcomes of hypertonic saline inhalation as a treatment modality in nontuberculous mycobacterial pulmonary disease.

Quantifying the Magnitude of Pharyngeal Obstruction During Sleep Using Airflow Shape.

Geographic distribution of COPD prevalence in the World displayed by Geographic Information System maps.

Moving Target - Shifting the Focus to Pulmonary Sarcoidosis as an Autoimmune Spectrum Disorder.

Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.

Severe asthma with blood hypereosinophilia associated with JAK2V617F mutation: a case series.

Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation.

A Genome-Wide Association Study implicates NR2F2 in Lymphangioleiomyomatosis Pathogenesis.

Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study.

Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease.

Exercising our options: comparing effects of exercise and positive expiratory pressure on mucociliary clearance.

The Medusa faces of dyspnoea in COPD.

Protecting those who serve: are we doing enough to prevent tuberculosis in healthcare workers?

Triple therapy in COPD: only for the right patient.

Predicting respiratory failure in amyotrophic lateral sclerosis: recruiting a few good pulmonologists.

Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.

Lung clearance index for early detection of pulmonary complications after allo‐HSCT in children

Pressure support ventilation, sigh adjunct to pressure support ventilation, and neurally adjusted ventilatory assist in infants after cardiac surgery: A physiologic crossover randomized study

Wheezing independently predicts viral infection in children with community‐acquired pneumonia

Exercise-related out-of-hospital cardiac arrest in Victoria, Australia

Interhospital transfer in low-volume and high-volume emergency departments and survival outcomes after out-of-hospital cardiac arrest: A nationwide observational study and propensity score–matched analysis

Sleep disorders in patients with primary ciliary dyskinesia, cystic fibrosis with and without pancreatic insufficiency

Normal polysomnography parameters in healthy adults: a systematic review and meta-analysis

New evidence on sleep ontogeny in adults

Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD

A review of the fate of inhaledα-quartz in the lungs of rats.

Exploring the science, safety, and benefits of air care products: perspectives from the inaugural air care summit.

Adherence to Long-Term Follow-Up of Patients with Life-Threatening, Inhaled Synthetic Cannabinoids-Associated Coagulopathy in Chicago

Prediction of peak oxygen uptake using the modified shuttle test— Methodological concerns and implications for clinical practice

Editorial introductions.

Editorial: Toward improving the diagnosis, treatment and prevention of community acquired and nosocomial respiratory tract infections.

Transmission and prevention of acute viral respiratory tract infections in hospitals.

Necrotizing pneumonia (aetiology, clinical features and management).

Precision medicine in the clinical management of respiratory tract infections including multidrug-resistant tuberculosis: learning from innovations in immuno-oncology.

Computed tomography scan contribution to the diagnosis of community-acquired pneumonia.

Outpatient management of community-acquired pneumonia.

Cardiovascular sequelae of pneumonia.

Comparing current US and European guidelines for nosocomial pneumonia.

New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.

Bronchiectasis phenotypes.

Inhaled antibiotics for the treatment of pneumonia.

The influence of genetics on therapeutic developments in pulmonary alveolar proteinosis.

Treatment of oncogene-driven non-small cell lung cancer.

Precision medicine: integration of genetics and functional genomics in prediction of bronchiolitis obliterans after lung transplantation.

Genetic profiling for disease stratification in chronic obstructive pulmonary disease and asthma.

Genetics in community-acquired pneumonia.